Kepos Capital’s Bristol-Myers Squibb BMY Stock Holding History

Kepos Capital’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-641	Closed	-$37K	–	228
2023 Q3	$37K	Buy	641 +96	+18%	+$5.88K	0.01%	208
2023 Q2	$35K	Buy	+545	New	+$36.5K	0.01%	261
2022 Q4	$37K	Buy	+511	New	+$38.5K	0.01%	274
2019 Q3	–	Sell	-55,654	Closed	-$2.52M	–	321
2019 Q2	$2.52M	Sell	55,654 -70,688	-56%	-$3.29M	0.26%	88
2019 Q1	$6.03M	Sell	126,342 -5,291	-4%	-$264K	0.45%	67
2018 Q4	$6.84M	Buy	+131,633	New	+$7.07M	0.53%	23
2018 Q2	–	Sell	-20,972	Closed	-$1.33M	–	331
2018 Q1	$1.33M	Sell	20,972 -15,484	-42%	-$996K	0.08%	158
2017 Q4	$2.23M	Buy	+36,456	New	+$2.28M	0.2%	112

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Kepos Capital's BMY Position: Q4 2023 in Review

Kepos Capital sold out of Bristol-Myers Squibb (BMY) in Q4 2023, closing a stake of 641 shares — an estimated $37K sold.

Kepos Capital first reported a position in BMY in Q4 2017 and held it in 8 quarters. The position peaked at $6.84M in Q4 2018. 2,363 funds tracked by Wall St. Rank hold BMY as of Q4 2023.

Kepos Capital reported no remaining Bristol-Myers Squibb position as of Q4 2023 after selling out during the quarter.
Kepos Capital sold 641 Bristol-Myers Squibb shares in Q4 2023, an estimated $37K.
Kepos Capital first reported a position in Bristol-Myers Squibb in Q4 2017 and held it in 8 quarters.
Kepos Capital's Bristol-Myers Squibb position peaked at $6.84M in Q4 2018.
2,363 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2023.

Based on Kepos Capital's 13F filing for Q4 2023, filed 12 Feb 2024.